Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion type Assertion NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_head.
- NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion description "[Results showed that IL-3-activated IL-4-dominant lymphocytes became IFN-?- dominant lymphocytes after combined HSV-sr39tk/GCV therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_provenance.
- NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion evidence source_evidence_literature NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_provenance.
- NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion SIO_000772 23441198 NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_provenance.
- NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion wasDerivedFrom befree-20140225 NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_provenance.
- NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_assertion wasGeneratedBy ECO_0000203 NP291722.RAvv9x3hnVMt6eEJFvJWGN0fUk-dUnOKyZVy4znjn_KH0130_provenance.